SBIR/STTR Research Award

Quantitative dual-mode scanner for breast cancer therapy

Award identifier a2e66e9ab121122cb13815e6ff1b972f0dc8b5781bcb503cf806a7bc4d127d74Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$275,148

Program and phase

STTR · Phase I

Award year

2013

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
PET/X LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
MUL8MGG1YQU4
Solicitation number
PA12-089
Topic code
NCI

Research abstract

DESCRIPTION (provided by applicant): The goal of this project is to develop a dual-mode PET/x-ray mammography scanner (PET/X) to improve the way in which breast cancer therapies are matched to patients by providing early evaluation of therapy efficacy through 'window' studies on an individual patient basis. More than 200,000 women in the US start therapy for breast cancer each year. In 2012 approximately 40,000 deaths will result from breast cancer. Often the first-line chemotherapies, hormonal therapies, and targeted therapies are not effective, requiring second- or third-line therapies. Unfortunately, the success of therapy is usually determined by waiting to see if there is a substantial reduction in tumor size, which may not occur until late in the course of treatment. Early assessment of treatment effectiveness will improve outcomes, reduce morbidity, and reduce cost. A compact PET imaging module that can be used as an add-on with X-ray mammography scanners will help inform the physician's choices of effective therapies for breast cancer patients. Early evaluation of a therapy's effectiveness will help the treating physician individualize a patient's treatment: A baseline (pre treatment) PET image will be taken, then, after a short regimen of a targetedtherapy, a post-therapy PET scan will be used to evaluate responses to treatment, and thus will be used to guide selection of post-surgery adjuvant therapy during the window of opportunity between diagnosis and surgery. For this treatment paradigm to become broadly accepted and widely used, the scanner needs to be higher resolution, more compact, and less expensive than standard whole-body PET scanners. In addition a high level of quantitative accuracy is needed. This Phase-I application will show proof ofprinciple of a detector multiplexing technology that substantially reduces costs for detector electronics for a compact high-resolution PET scanner suitable for breast cancer imaging. By using optimal multiplexing technologies for the detector readout electronics, the number of signal channels can be dramatically reduced, thus reducing cost, while still meeting quantitative imaging performance goals. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: We are working to develop and commercialize a compact positron emission tomography (PET) imaging module that can be used as an add-on with X-ray mammography scanners. The PET/X scanner is targeted for use with breast cancer patients to select and monitor the choice of the most effective therapy. In thisPhase-I application we will show proof of principle of a detector multiplexing technology that will substantially reduce costs for detector electronics for a compact high-resolution PET scanner suitable for breast cancer imaging. By using optimal multiplexing technologies for the detector readout electronics, we can dramatically reduce the number of signal channels, and thus cost, while still meeting quantitative imaging performance goals.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

4 SBIR/STTR records share this UEI (2013–2020). Reported award amounts total $2,902,459. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.